1. C. Burtin, C. Noirot, P. Scheimann, L. Gallopin, D. Sabolovic and P. Bernhard,Clinical improvement in advanced cancer disease after treatment combining histamine and H 2 anthistaminics (Ranitidine or Cimetidine) Eur. J. Cancer Clin. Oncol.24, 161–167 (1988).
2. B. C. Tilly, L. G. Tertoolen, R. Remorie, A. Ladoux, I. Verlaan, S. W. de Aat and W. H. Moolenaar,Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: Action through Ca 2+ mobilizing H 1 receptors. J. Cell. Biol.110, 1211–1215 (1990).
3. R. Seifert, A. Höer, I. Schwaner and A. Buschauer,Histamine increases cytosolic Ca 2+ gin HL-60 promyelocytes predominantly via H 2-receptors with an unique agonist/antagonist profile and induces functional differentiation. Mol. Pharmacol. (in press).
4. A. Venturio, E. S. Rivera, R. M. Bergoc and R. A. Caro,A simplified competition data analysis for radioligand specific activity determination. Nucl. Med. Biol.17, 233–237 (1990).
5. E. S. Rivera, A. M. Actis, G. Martin, R. M. Bergoc and E. Lewin,Growth factors and hormone dependence in breast cancer. Acta Bioq. Clin. Latinoamer. (in press).